Advanced Molecular Technologies
Advanced Molecular Technologies (AMT) is a privately held Australian CRO and specialty chemical manufacturer offering custom organic synthesis, analytical services, and a catalogue of organoborons, PEG linkers, fluorophores, and ionisable lipids to pharmaceutical, biotech, agricultural, and academic clients globally.
- Company typePrivate
- Founded2005
- HeadquartersScoresby, Australia
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Advanced Molecular Technologies does
Advanced Molecular Technologies Pty Ltd (AMT) is an Australian privately held contract research organisation (CRO) and specialty chemical manufacturer headquartered in Scoresby, Victoria, founded in 2005. The company operates a 1-10 person laboratory focused on medicinal chemistry, custom organic synthesis, and a broad catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, halogenated organics, diaryls, catalysts, bioactives, PEG reagents and linkers, and fluorophores and dyes. Core service offerings comprise custom synthesis (route design, target molecule synthesis, structure-based drug design, metabolite and impurity synthesis, GLP-compliant production for in vivo studies) and fee-for-service analytical chemistry using a Bruker Avance III 400 MHz NMR, Waters HPLC, PerkinElmer GC, Agilent FT-IR, and supporting instrumentation. AMT also incubates proprietary biotech programmes in organoboron pharmaceuticals and diagnostics, PEG linkers for antibody-drug conjugates, and AMPK activators.
AMT makes money through three distinct streams: (i) professional-service custom synthesis contracts with pharmaceutical, biotech, agricultural, and academic clients, (ii) one-time catalogue chemical product sales at unit prices typically ranging from approximately AUD $80 to $780 per pack, and (iii) usage-based analytical service fees starting at AUD $25 per 1H NMR sample. The company employs a sales-led direct go-to-market via its website, phone, and email, supplemented by an international channel partner network: Frontier Specialty Chemicals distributes AMT PEG products in the US (announced November 2025), Key Organics holds an exclusive European supply and marketing agreement under the BIONET brand (since September 2013), IDT Australia provides GMP manufacturing collaboration for clinical and commercial PEG linker supply (since December 2023), and Scaled Organics and AK Scientific act as additional distribution partners. End customers include pharmaceutical and biotechnology companies (primary segments), agricultural chemical firms, and academic and research institutions across Australia, North America, Europe, and Japan.
Advanced Molecular Technologies firmographics
Firmographics- Name
- Advanced Molecular Technologies
- Legal name
- Advanced Molecular Technologies Pty Ltd
- Website
- https://amtechpl.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Advanced Molecular Technologies (AMT) is a privately held Australian CRO and specialty chemical manufacturer offering custom organic synthesis, analytical services, and a catalogue of organoborons, PEG linkers, fluorophores, and ionisable lipids to pharmaceutical, biotech, agricultural, and academic clients globally.
- Ownership category
- akta.pro rank
Advanced Molecular Technologies industry classification
Industry- Product category
- Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (541380), Other Scientific and Technical Consulting Services (541690), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Custom Intermediates & Advanced Intermediates Manufacturing (HLAGAHAH)
- akta.pro secondary industry
- Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
Keywords
Where Advanced Molecular Technologies is headquartered
LocationHeadquarters
- HQ city
- Scoresby
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Advanced Molecular Technologies business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Custom Synthesis Contracts: AMT provides contract research and custom synthesis services to pharmaceutical, biotech, agricultural and academic institutions. Services include route design, target molecule synthesis, drug discovery, and process scale-up.
- Catalogue Chemical Product Sales: Sale of in-stock specialty chemicals including organoborons, organosilicons, nucleosides, halogenated organics, diaryls, catalysts, bioactives, PEG reagents and linkers, and fluorophores and dyes. Products are sold in various pack sizes with unit-based pricing.
- Analytical Services: Fee-for-service analytical testing including NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, Polarimetry, DSC, Flash Point, and Biotage Flash Purification. Samples from $25.00 AUD per 1H NMR.
- GMP Manufacturing Services: Through collaboration with IDT Australia, AMT supports the development and GMP manufacturing of polyethylene glycol (PEG) linkers for clinical and commercial supply.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Unit pricing for catalogue chemical products |
| Usage-based | Pay-as-you-go | NMR analytical service pricing |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels4 records
Advanced Molecular Technologies product offering
Product offeringCore offering
Advanced Molecular Technologies (AMT) is a contract research organisation and biotech incubator specialising in medicinal chemistry and custom organic synthesis. The company provides custom synthesis of target molecules, analytical chemistry testing services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC), and a catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, PEG linkers for ADCs, and fluorophores for pharmaceutical, biotech, agricultural and academic customers. AMT also supports GMP manufacturing of PEG linkers for clinical and commercial supply through its collaboration with IDT Australia.
Product overview
Advanced Molecular Technologies (AMT) operates as a biotech incubator and contract research organization (CRO) specializing in medicinal chemistry and custom organic synthesis. The company's portfolio combines core service offerings with a comprehensive catalog of specialty chemical products. Core services include Custom Organic Synthesis (route design, target molecule synthesis, GLP production for in vivo studies) and Analytical Services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC, flash point testing). The product catalog spans multiple chemical categories: General Chemicals, Organoborons, Organosilicons, Nucleosides, Halogenated Organics, Diaryls, Catalysts, Bioactives, PEG Reagents and Linkers (critical for antibody-drug conjugates and bioconjugate technologies), and Fluorophores and Dyes. AMT also incubates organoboron pharmaceuticals, diagnostics, PEG linkers for ADCs, and AMPK activators. Featured products include ionisable lipids such as Lipid 5, ALC-0315, and SM-102 used in advanced therapeutic modalities.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom Organic Synthesis Services Contract research service for custom synthesis of target molecules for pharmaceutical, biotech, and chemical markets. Includes route design, traditional synthesis of complex molecules, production of pharmacologically active reference compounds, structure-based drug design, scaffolds, building blocks, lead optimisation, and synthesis of metabolites, impurities and reference compounds, plus GLP-compliant compounds for in vivo studies.
- Analytical Services Fee-for-service analytical chemistry testing including NMR (1H, 13C, 10B, 15N, 19F, 29Si, 31P), HPLC (NP/RP, chiral and achiral), GC, FT-IR, UV-Vis, Karl Fischer titration, Polarimetry, Thermogravimetric Analysis, DSC, Closed Cup Flash Point Testing, and Biotage SP4 Flash Purification. Targeted at pharmaceutical, biotech, academic and chemical industry customers.
- GMP Manufacturing of PEG Linkers Managed-service GMP manufacturing collaboration with IDT Australia for development and production of polyethylene glycol (PEG) linkers. AMT contributes linker chemistry expertise, custom synthesis, process development and scale-up; IDT Australia provides GMP manufacturing, analytical testing, quality systems and regulatory support for clinical and commercial supply. Targeted at ADC developers across North America, Japan and other global pharmaceutical markets.
- General Chemicals Catalogue Broad catalogue of general chemical compounds available for research and industrial applications, sold in various pack sizes with unit-based pricing.
- Organoborons Catalogue Catalogue of organoboron compounds used in cross-coupling reactions and pharmaceutical research, sold in catalogue pack sizes (mg to g) with unit pricing.
- Organosilicons Catalogue Catalogue of organosilicon compounds including HOMSi reagents for Hiyama cross-coupling reactions, sold with unit-based pricing.
- Nucleosides Catalogue Catalogue of nucleoside compounds for pharmaceutical and biotech research applications, sold with unit-based pricing.
- PEG Reagents and Linkers Catalogue Catalogue of polyethylene glycol (PEG) reagents and linkers for antibody-drug conjugates (ADCs), peptide conjugates, and bioconjugate technologies, available in catalogue and bulk quantities including GMP quality materials.
- Fluorophores and Dyes Catalogue Catalogue of fluorescent probes and dyes for research and diagnostic applications, including products such as DBD-F (4-(N,N-Dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole).
- Bioactives Catalogue Catalogue of biologically active compounds for pharmaceutical and biotech research, sold with unit-based pricing.
- Halogenated Organics Catalogue Catalogue of halogenated organic compounds for synthesis and research applications, sold with unit-based pricing.
- Diaryls Catalogue Catalogue of diaryl compounds for pharmaceutical and chemical research, sold with unit-based pricing.
- Catalysts Catalogue Catalogue of catalytic compounds for organic synthesis reactions, sold with unit-based pricing.
- ALC-0315 (AMTGC903-AL21) Featured ionisable lipid compound sold in 500mg ($310 AUD) and 1g ($470 AUD) pack sizes, used in lipid nanoparticle formulations for advanced therapeutics.
- Lipid 5 (AMTGC1533-LP25) Featured ionisable lipid compound sold in 500mg ($390.00 AUD) and 1g ($595.00 AUD) pack sizes, used in lipid nanoparticle formulations for advanced therapeutics.
- SM-102 (AMTGC936-SM21) Featured ionisable lipid compound for pharmaceutical applications, sold in 500mg ($420 AUD) and 1g ($680 AUD) pack sizes.
Companies that use Advanced Molecular Technologies
Customer profileSegments4 records
Ideal customer profiles4 records
Advanced Molecular Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Advanced Molecular Technologies partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Frontier Specialty ChemicalscoreDistribution partnership with Frontier Specialty Chemicals to enhance customer access to AMT's portfolio of high-purity functionalised PEGs for customers across the US. Frontier serves as a distribution and customer support partner, providing local sales, order management, and customer service. Inventory is located in the US to avoid customs delays. Products are available in catalogue and bulk quantities, as well as GMP quality materials.
- IDT AustraliacoreCollaboration with IDT Australia to provide a streamlined pathway for the development and GMP manufacturing of polyethylene glycol (PEG) linkers. AMT contributes expertise in linker chemistry, custom synthesis, process development, and scale-up. IDT Australia provides GMP manufacturing capabilities, analytical testing, quality systems, and regulatory support for clinical and commercial supply. The collaboration supports customers across North America, Japan, and other global pharmaceutical markets.
- Key OrganicscoreExclusive European supply and marketing agreement. Key Organics distributes AMT products under its BIONET brand. Key Organics has an extensive range of over 65,000 screening compounds, intermediates, building blocks and biochemicals and access to global customer base within the global life sciences sector. Both companies collaborate to grow their differentiated technology and service offerings.
- Scaled OrganicsminorListed as a distribution partner on AMT's partners page. Scaled Organics is a custom synthesis and chemical supply company.
- AK ScientificminorListed as a distribution partner on AMT's partners page. AK Scientific is a custom synthesis and chemical supply company.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Advanced Molecular Technologies competitors and assessment
Company assessmentDirect peers
- Enamine: Ukraine-based global supplier of building blocks, screening compounds, and custom synthesis services with a catalogue exceeding 250,000 compounds. Directly comparable to AMT as a catalogue-plus-custom-synthesis CRO serving pharma and academic customers.
- Bide Pharmatech: China-based supplier of building blocks, intermediates, and custom synthesis services. Comparable to AMT as a custom synthesis CRO with an extensive catalogue, focused on pharma and biotech drug discovery customers.
- PharmaBlock Sciences: China-headquartered provider of building blocks, intermediates, custom synthesis, and process R&D services to the pharmaceutical industry. Comparable to AMT across custom synthesis, building blocks, and reference compounds, with greater scale and GMP capacity.
- Oakwood Chemical: US-based manufacturer and distributor of specialty organic chemicals, including fluorinated compounds, organometallics, and building blocks. Comparable to AMT as a catalogue chemistry supplier serving pharma, biotech, and academic customers.
- Combi-Blocks: US-based supplier of chemical building blocks, screening compounds, and custom synthesis services for drug discovery. Directly comparable to AMT across catalogue building blocks, custom synthesis, and CRO services for pharmaceutical/biotech customers.
- Key Organics: UK-based supplier of screening compounds, building blocks, intermediates, and biochemicals (65,000+ compounds under BIONET brand). Directly comparable as a catalogue chemistry and custom synthesis peer, and additionally serves as AMT's exclusive European distribution partner.
Broad incumbents
- Alfa Aesar (Thermo Fisher Scientific): Global catalogue supplier of research chemicals, metals, and materials under Thermo Fisher Scientific. Overlaps with AMT's catalogue offerings (organics, building blocks, specialty chemicals) and serves the same pharma/biotech/academic customer base.
- Sigma-Aldrich (Merck KGaA / MilliporeSigma): Global incumbent in research chemicals, analytical standards, and life science products. Overlaps with AMT's catalogue chemical business and analytical reagents, but at vastly greater scale and breadth across all research chemistries.
- Tokyo Chemical Industry (TCI): Japan-based global supplier of organic chemicals, reagents, and custom synthesis services. Comparable to AMT across organics, organometallics, and catalogue chemistry, with a far larger catalogue and established international distribution.
Emerging players
- Frontier Specialty Chemicals: US-based specialty chemicals distributor with focused PEG/bioconjugation product line. Comparable to AMT as a PEG-focused supplier to pharma/biotech, and additionally serves as AMT's US distribution partner for PEG products.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Advanced Molecular Technologies social profiles
Digital presenceAdvanced Molecular Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Advanced Molecular Technologies leadership team
Management profileNumber of profiles
Advanced Molecular Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Advanced Molecular Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Advanced Molecular Technologies
What does Advanced Molecular Technologies do?
Advanced Molecular Technologies (AMT) is a contract research organisation and biotech incubator specialising in medicinal chemistry and custom organic synthesis. The company provides custom synthesis of target molecules, analytical chemistry testing services (NMR, HPLC, GC, FT-IR, UV-Vis, Karl Fischer, polarimetry, DSC), and a catalogue of specialty chemicals including organoborons, organosilicons, nucleosides, PEG linkers for ADCs, and fluorophores for pharmaceutical, biotech, agricultural and academic customers. AMT also supports GMP manufacturing of PEG linkers for clinical and commercial supply through its collaboration with IDT Australia.
Is Advanced Molecular Technologies a public or private company?
Advanced Molecular Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Advanced Molecular Technologies founded?
Advanced Molecular Technologies was founded in 2005. It employs 1 to 10 people.
Where is Advanced Molecular Technologies based?
Advanced Molecular Technologies is headquartered in Scoresby, Australia, in the Oceania region.
How does Advanced Molecular Technologies make money?
Four revenue lines are on record. Custom Synthesis Contracts are the primary driver. The others are catalogue Chemical Product Sales, analytical Services and GMP Manufacturing Services.
Who are Advanced Molecular Technologies's main competitors?
Direct peers on record are Enamine, Bide Pharmatech, PharmaBlock Sciences, Oakwood Chemical, Combi-Blocks and Key Organics. Broad incumbents are Alfa Aesar (Thermo Fisher Scientific), Sigma-Aldrich (Merck KGaA / MilliporeSigma) and Tokyo Chemical Industry (TCI). Frontier Specialty Chemicals is listed as an emerging player.
Does Advanced Molecular Technologies have an API?
No public API is recorded for Advanced Molecular Technologies.
What industry is Advanced Molecular Technologies in?
Advanced Molecular Technologies's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAHAH, Custom Intermediates & Advanced Intermediates Manufacturing, with a secondary code of HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization. Its NAICS code is 541714 and its SIC code is 8731.